IVD Packaging: Sterile Barrier Requirements and EU IVDR Compliance

What Is IVD Packaging?

In vitro diagnostic (IVD) medical device packaging encompasses all packaging systems used to contain, protect, and present IVD products from manufacture to the point of use. IVDs include a broad range of products: rapid antigen test kits, lateral flow assays, blood glucose test strips, PCR reagents, microbiological culture media, sample collection containers, clinical analyser reagent cartridges, and laboratory instruments or their accessories.

Unlike many medical devices that require only physical protection, IVD packaging must often also provide a defined chemical environment — controlling moisture, oxygen, and light exposure — to preserve reagent integrity and ensure consistent diagnostic performance throughout the product's stated shelf life. A package that fails to maintain the specified humidity level may render a diagnostic test inaccurate, with direct patient safety implications, even if the sterile barrier itself remains intact.

IVD packaging requirements derive from two regulatory sources: the requirements imposed by the IVD regulation (EU IVDR 2017/746 in Europe; FDA 21 CFR Part 820 in the US) and the performance requirements of the IVD product itself, as established during product stability and shelf-life validation. Both must be addressed in the technical documentation.

EU IVDR Packaging Requirements

EU Regulation 2017/746 (the In Vitro Diagnostic Regulation, IVDR) replaced the In Vitro Diagnostic Directive (IVDD 98/79/EC) and significantly strengthened requirements for IVD packaging, labeling, and technical documentation. For manufacturers of sterile IVDs — or IVDs supplied in a defined microbial state — the IVDR imposes specific packaging-related obligations under Annex I (General Safety and Performance Requirements).

GSPR 20: Packaging and Transportation Requirements

GSPR 20.3 is the most packaging-specific GSPR under IVDR: "The packaging shall clearly identify the sterile barrier system." This requirement, introduced under IVDR and not present under the prior IVDD, mandates use of the ISO 15223-1:2021 oval-shaped sterile barrier symbols — a solid-line oval for the sterile barrier itself and a dashed-line oval for protective packaging that is not itself the sterile barrier. This symbol requirement applies to all IVDs supplied in a sterile condition, regardless of product class.

GSPR 20.1 requires that IVDs "be designed and manufactured so that their characteristics and performance during transport and storage are not adversely affected when handled in accordance with the instructions and information provided by the manufacturer." For packaging, this requires validated evidence that the packaging system — and its contents — maintain performance after exposure to specified distribution and storage conditions.

GSPR 20.2 requires that packaging allows the sterile product to be transported and stored without adverse changes to the defined sterile or microbial state. This maps directly to the ISO 11607-1 requirements for sterile barrier integrity, and compliance is typically demonstrated through distribution simulation (ASTM D4169 or ISTA protocols) combined with post-stress seal integrity testing. For seal integrity test method selection, see the seal integrity testing guide.

Common IVD Packaging Formats

The choice of IVD packaging format is driven by three primary constraints: the physical form of the IVD product, the required barrier properties, and the intended use setting (laboratory, point-of-care, home use).

Cold-Form Foil Blisters

Cold-form aluminum foil blister packs are the dominant format for individually packed diagnostic test strips, rapid antigen tests, and moisture-sensitive reagents. The aluminum foil barrier provides essentially zero moisture vapor transmission (MVTR) and oxygen transmission rate (OTR), protecting hygroscopic components and enzymatic reagents from environmental degradation. Each test unit is individually sealed, providing product integrity verification at the point of opening and allowing partial-kit use without compromising the remaining units.

Thermoformed PETG Blisters

Transparent PETG blisters are used for IVD products that do not require high moisture or gas barriers — sample collection containers, swabs, lancets, and related accessories — where device visibility and physical protection are the primary requirements. PETG blisters sealed with Tyvek allow EtO sterilization for sterile collection devices and provide good physical impact resistance during distribution.

Flexible Pouch Configurations

Flexible multi-layer pouches are used for reagent kits containing multiple components — cartridges, tubes, and accessories — that must be co-packaged in a single sterile environment. Pouches are typically constructed from PET/aluminum/PE or PET/PVDC/PE laminates depending on barrier requirements. High-barrier pouches with desiccant inserts are common for reagent cartridges used in automated analyser systems, where a single cartridge may contain multiple reagent types each sensitive to moisture or oxygen.

Rigid Tray with Peel Lid

Rigid PP or PETG trays with peel lids — either Tyvek or film laminates — are used for IVD kits that contain multiple individual items requiring aseptic presentation. This format is common for point-of-care testing kits where multiple reagent vials, sample containers, and consumables must be presented to the user in an organized, contamination-controlled manner.

Material Selection for IVD Applications

IVD packaging material selection must address both the packaging performance requirements (ISO 11607-1) and the product stability requirements established during IVD development and validation. The interaction between packaging material properties and reagent stability must be explicitly evaluated.

Key material performance parameters for IVD packaging include: MVTR (moisture vapor transmission rate); OTR (oxygen transmission rate); extractable and leachable profile; compatibility with desiccants (silica gel, molecular sieves); and compatibility with the specific sterilization method used (if sterile packaging is required).

For a comprehensive comparison of materials and their sterilization compatibility, see the Tyvek medical packaging guide, and for a broader material selection framework, refer to the ISO 11607 compliance guide.

Packaging Validation for IVDs

Packaging validation for IVD products encompasses two interdependent streams: the packaging system integrity validation (per ISO 11607-2) and the IVD product stability validation (per manufacturer-specific protocols and IVDR Annex I GSPR requirements). Both streams must be documented separately and cross-referenced in the technical documentation.

Packaging System Integrity Validation

For sterile IVD packaging, ISO 11607-2 requires IQ/OQ/PQ validation of all forming and sealing processes. For cold-form blister packs, this covers the cold-forming press, the sealing station, and any integrated inspection systems. For flexible pouches, validation covers the sealing equipment parameters — temperature, pressure, dwell time — across the full production range.

Post-validation, packaging integrity must be demonstrated through distribution simulation and accelerated aging. The ASTM F1980 accelerated aging methodology — using the Q10 factor to convert accelerated study time to real-time equivalents — is the standard approach for establishing initial shelf life claims. Real-time confirmation studies must run concurrently. For the complete accelerated aging methodology, see the ASTM F1980 guide.

IVD Product Stability Validation

IVD product stability validation must demonstrate that diagnostic performance — sensitivity, specificity, accuracy, and precision — is maintained throughout the stated shelf life under the specified storage conditions. Packaging plays a direct role in this validation: the packaging system's moisture and oxygen barrier properties define the microenvironment in which the reagent ages. A change in packaging material or configuration may require full repetition of stability studies.

Labeling Requirements Under IVDR

IVDR Annex I Section 20 and the labeling provisions in Article 10(11) establish specific labeling requirements for IVD packaging. For sterile IVDs, the sterile barrier layer must be identified using the ISO 15223-1:2021 oval-shaped symbols, as described above. Additional required information on the sterile package label includes the sterility method symbol, lot number, use-by date, manufacturer details, and a warning against using damaged packaging.

Sterile vs. Non-Sterile IVD Packaging

Frequently Asked Questions

Do non-sterile IVDs need to comply with ISO 11607?

ISO 11607 applies specifically to sterile medical device and IVD packaging. Non-sterile IVDs do not need to comply with ISO 11607 as a harmonized standard, but the packaging must still demonstrate that it maintains the defined product performance characteristics throughout the stated shelf life. Many non-sterile IVDs require high moisture and oxygen barriers that de facto require similar material qualification activities to those defined in ISO 11607-1.

When is a desiccant required in IVD packaging?

A desiccant is required in IVD packaging when the product (reagent, test strip, or component) is hygroscopic to a degree that would compromise diagnostic performance if exposed to ambient moisture levels during storage and use. Desiccants (silica gel, molecular sieves) are incorporated into the sealed package — typically as a sachet or canister — and their capacity must be validated to maintain the required headspace humidity for the full stated shelf life. Desiccant selection and sizing is part of the packaging system design and must be included in the packaging validation protocol.

What distribution simulation standard applies to IVD packaging?

ASTM D4169 (Performance Testing of Shipping Containers and Systems) and ISTA test procedures are the primary distribution simulation standards used for IVD packaging. ASTM D4169 Assurance Level II is commonly specified. The choice of cycle (Cycle A through G) and climate conditioning should reflect the intended distribution environment — for IVDs distributed in controlled-temperature cold chains, additional climate conditioning cycles are required. Distribution simulation results must be evaluated against the defined packaging integrity acceptance criteria.

Does IVDR apply to point-of-care test kits sold for home use?

Yes. Self-tests (home use IVDs) are classified under IVDR and subject to its full requirements, including packaging labeling and validation requirements. Self-tests are typically classified as Class B or higher under IVDR Annex VIII, requiring Notified Body involvement for most product categories. The labeling requirements for self-tests are the same as for professional-use IVDs, though additional plain-language information requirements apply to facilitate safe consumer use.

How does accelerated aging for IVD packaging differ from medical device packaging?

The methodology for accelerated aging of IVD packaging follows the same ASTM F1980 Q10 framework used for medical device packaging. However, for IVDs, accelerated aging studies must address not only the packaging seal integrity (as for medical devices) but also the functional performance of the reagents or active components at end of shelf life. The temperature and humidity conditions selected for accelerated aging must therefore be compatible with reagent stability — aggressive temperatures that accelerate packaging aging may also cause disproportionate reagent degradation that does not reflect real-time behavior. This interaction must be justified in the study design. For the full accelerated aging methodology, see the ASTM F1980 guide.

External references: EU IVDR 2017/746 (EUR-Lex) · ISO 11607-1:2019 (ISO.org)